Surgery increases risk of conjunctival scars

Article

A greater number of mast cells are present in the conjunctiva of glaucoma patients who have undergone ocular surgery, possibly leading to increased scarring, according to study results published online ahead of print by Eye.

A greater number of mast cells are present in the conjunctiva of glaucoma patients who have undergone ocular surgery, possibly leading to increased scarring, according to study results published online ahead of print by Eye.

Lydia Chang of the Paediatric Glaucoma Service at Moorfields Eye Hospital, London, UK and colleagues identified the presence of tryptase, the intracellular mast cell enzyme, in the conjunctiva of glaucoma patients treated medically (n=6), with repeated surgery (n=8) and for uveitic glaucoma (n=7). They compared the tryptase levels with those found in the conjunctival biopsies of the control group (retinal detachment patients, n=8).

The median tryptase level of the control group was 0.064 cells/mm2; among the glaucoma groups, the median level ranged from 0.102 cells/mm2 to 0.113 cells/mm2. There was a statistically significant difference between the tryptase level of the surgery glaucoma group when compared with control, although this statistically significant difference did not exist between the control group and either of the other glaucoma groups.

Because the tryptase levels were higher in glaucoma patients who had previously undergone surgery, the researchers concluded that the activity of mast cells may contribute to post-trabeculectomy conjunctival scarring.

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.